CAP defines a second signalling pathway required for insulin-stimulated glucose transport by Baumann, Christian A. et al.
letters to nature
202 NATURE | VOL 407 | 14 SEPTEMBER 2000 | www.nature.com
of each sample was mixed with 4 ´ Laemmli SDS±PAGE buffer, boiled for 4 min at 98 8C
and resolved by SDS±PAGE.
Protein reconstitution into vesicles
For acceptor vesicles containing t-SNAREs, 60 ml of Vam3 (2.9 mg ml-1), 200 ml of His6±
Vam7 (8.2 mg ml-1) and/or 20 ml of His6±Vti1 (14 mg ml
-1) were mixed and 20 ml of 10%
octyl-b-D-glucopyranoside and 250 ml of reconstitution buffer were added. After incu-
bation at 4 8C for 20 h, 500 ml of the reaction was used for reconstitution of acceptor
vesicles. For donor vesicles containing the v-SNARE, 100 ml of GST±Nyv1 (3.6 mg ml-1)
was used. SNAREs were reconstituted as described2 except that all the buffers used for
reconstitution contained 500 mM KCl. The principal lipid components in the liposomes
were 85% DOPC (1,2-dioleoyl phosphatidylcholine) and 15% DOPS (1,2-dioleoyl
phosphatidylserine). Typical lipid concentration in the recovered Nycodenz fractions
containing the vesicles were 0.7±0.9 mM for donor vesicles and 1.8±2.5 mM for acceptor
vesicles. Concentrations of GST±Nyv1 in donor vesicle fractions were 0.7±0.8 mg ml-1
and those of t-SNARE complex in acceptor vesicles were 0.45±0.5 mg ml-1, corresponding
to a 16% and 9% reconstitution ef®ciency. For preparation of vesicles containing vacuolar
lipids29,30, we used the following lipid mixture: DOPC (1,2-dioleoyl phosphatidylcholine)/
DOPE (1,2-dioleoyl phosphatidylethanolamine)/ soybean PI (phosphatidylinositol)/
DOPS (1,2-dioleoyl phosphatidylserine)/ DOPA (1,2-dioleoyl phosphatidic acid)/ heart
cardiolipin in a 53:20:19:5:2:1 molar ratio. All lipids were obtained from Avanti Polar
Lipids. The reconstitution ef®ciencies for v-SNAREs and t-SNAREs in vacuolar lipid
mixtures were 8% and 9%, respectively.
Lipid mixing assay
Lipid mixing assay was carried out as described2,15, except that n-dodecylmaltoside was
used to determine the maximum NBD signal instead of Triton X-100. Rounds of fusion
were determined by using a calibration curve which was prepared as described16, except
that GST±Nyv1 was used instead of VAMP to reconstitute vesicles and that the mixtures of
labelled and unlabelled lipids corresponded to one-, two-, three-, four-, or sixfold dilutions
of donor ¯uorescent lipid. The equation used to convert the percentage dodecylmaltoside
signal to rounds of fusion is y = (0.52247 ´ e(0.032993x)) - (0.527 ´ e(-0.074915x)) where y is the
rounds of fusion and x is the percentage dodecylmaltoside signal at a given time interval.
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Insulin stimulates the transport of glucose into fat and muscle
cells. Although the precise molecular mechanisms involved in this
process remain uncertain, insulin initiates its actions by binding
to its tyrosine kinase receptor, leading to the phosphorylation of
intracellular substrates. One such substrate is the Cbl proto-
oncogene product1. Cbl is recruited to the insulin receptor by
interaction with the adapter protein CAP, through one of three
adjacent SH3 domains in the carboxy terminus of CAP2. Upon
phosphorylation of Cbl, the CAP±Cbl complex dissociates from
the insulin receptor and moves to a caveolin-enriched, triton-
insoluble membrane fraction3. Here, to identify a molecular
mechanism underlying this subcellular redistribution, we screened
a yeast two-hybrid library using the amino-terminal region of
CAP and identi®ed the caveolar protein ¯otillin. Flotillin forms a
ternary complex with CAP and Cbl, directing the localization of
the CAP±Cbl complex to a lipid raft subdomain of the plasma
membrane. Expression of the N-terminal domain of CAP in
3T3-L1 adipocytes blocks the stimulation of glucose transport by
insulin, without affecting signalling events that depend on
phosphatidylinositol-3-OH kinase. Thus, localization of the
Cbl±CAP complex to lipid rafts generates a pathway that is crucial
in the regulation of glucose uptake.
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To identify proteins that may participate in the localization and
function of Cbl and CAP, we screened a yeast two-hybrid library
derived from 3T3-L1 adipocytes4 using as bait the N-terminal
region of CAP, which contains the sorbin homology domains but
lacks the SH3 domains (CAPDSH3, Fig. 1a). Three independent
clones were isolated encoding the protein ¯otillin5. To examine the
binding speci®city of ¯otillin and CAP, we incubated glutathione-S-
sepharose-bound ¯otillin (GST±¯otillin) with lysates from human
embryonic kidney (HEK293T) cells overexpressing either Flag-
epitope-tagged full-length CAP or Flag-epitope-tagged CAPDSH3.
As seen in Fig. 1b, GST±¯otillin bound to both Flag±CAP and Flag±
CAPDSH3. It also precipitated endogenous Cbl from the extracts in
the presence of CAP but not when CAPDSH3 was co-expressed.
These data indicate that the interaction of ¯otillin with Cbl requires
full-length CAP to form a ¯otillin±CAP±Cbl ternary complex.
Triton-insoluble microdomains of the plasma membrane have
been implicated in signal transduction6,7. Flotillin is an integral
membrane protein that associates with the triton-insoluble fraction
enriched in the caveolar protein caveolin5. Moreover, ¯otillin can
physically associate in hetero-oligomeric structures with caveolin in
detergent-solubilized cells8. The physiochemical properties of pro-
teins that are enriched in lipid rafts make it dif®cult to perform
standard, triton-soluble, co-immunoprecipitation assays. We there-
fore examined the subcellular localization of CAP, CAPDSH3,
endogenous caveolin and ¯otillin by confocal immuno¯uorescence
microscopy of intact cells and by immuno¯uorescence following
preparation of plasma membrane sheets. After transfection of
3T3-L1 adipocytes by electroporation9, both Flag±CAP and Flag±
CAPDSH3 showed diffuse staining of the cytoplasm, with a sig-
ni®cant portion found nonuniformly distributed around the
plasma membrane (see Supplementary Information Fig. 1). Immu-
nostaining of endogenous caveolin followed by a Texas Red sec-
ondary antibody revealed caveolin in the plasma membrane, as
reported6,7. Merging the two images shows that a signi®cant portion
of both CAP and CAPDSH3 proteins are found at the plasma
membrane, similar to the endogenous caveolin I.
To examine the plasma membrane localization of caveolin in
relation to ¯otillin, we prepared plasma membrane sheets from
3T3-L1 adipocytes and immunostained them with antibodies to
caveolin and ¯otillin. Caveolin and ¯otillin were localized together
in circular rosette structures in the plasma membrane (see Supple-
mentary Information Fig. 2). The co-distribution of ¯otillin and
caveolin in the plasma membrane was unaffected by insulin stimu-
lation. These ¯otillin and caveolin-enriched structures probably
consist of collections of caveolae or lipid rafts10.
To investigate further the dynamics of endogenous Cbl protein
association with ¯otillin, we took a similar approach using immuno-
¯uorescence of isolated plasma membrane sheets (Fig. 2). As
described above, exposure of cells to insulin for 2±60 min had no
effect on the overall plasma membrane distribution of ¯otillin.
Although Cbl was not detected in the plasma membrane sheets in
the basal state, there was transient translocation of Cbl to the plasma
membrane, which was apparent after 2 and 5 min of insulin stimula-
tion. This time-dependent translocation of Cbl to the plasma


































Figure 1 CAP and Cbl form a ternary complex with GST±¯otillin. a, Flag-epitope-tagged
expression constructs of CAP and CAPDSH3 mutant. b, Flag-epitope-tagged CAP (left) or
CAPDSH3 (right) overexpression lysates from HEK293T cells were incubated with either
glutathione agarose or glutathione-agarose-bound GST±¯otillin for 1 h at 4 8C.
Precipitates were subjected to SDS±polyacrylamide gel electrophoresis (PAGE),
transferred to nitrocellulose and blotted with monoclonal Flag M2 antibody (Stratagene)
and polyclonal c-Cbl antibody (Santa Cruz).
Figure 2 Translocation of Cbl to caveolin- and ¯otillin-containing plasma membrane
subdomains of 3T3-L1 adipocytes. Representative confocal immuno¯uorescence images
of ¯otillin and Cbl localized to plasma membrane sheets isolated from basal cells or those
treated with insulin (Ins) for the indicated times. The colocalization of FITC-labelled ¯otillin
and Texas Red-labelled Cbl is shown.
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tyrosine phosphorylation11. Furthermore, merging of these images
showed that Cbl localized with ¯otillin in rosette-type structures,
again suggesting the insulin-dependent formation of a ternary
¯otillin±CAP±Cbl complex.
Finally, to assess biochemically the relationship between caveolin,
¯otillin and Cbl, we subjected basal and insulin-stimulated 3T3-L1
adipocytes to non-detergent homogenization and sucrose gradient
fractionation (see Supplementary Information Fig. 3). Consistent
with the immuno¯uorescence of isolated plasma membrane sheets,
caveolin was found primarily in the low-density membrane regions
of these gradients (fractions 3 and 4), and was not affected by insulin
treatment. Similarly, ¯otillin was found in the fractions containing
caveolin. Cbl was primarily con®ned to the dense regions of the
gradient (fractions 8±12) in the basal state. However, following
insulin stimulation, a portion of the Cbl protein was redistributed to
the low-density fractions containing caveolin and ¯otillin. Together,
these data provide strong evidence that caveolin and ¯otillin are
colocalized in distinct subdomains of the plasma membrane, and
that insulin induces the translocation of Cbl to these caveolin- and
¯otillin-enriched compartments through its interaction with CAP.
To assess the potential role of CAP in early signalling events, we
next overexpressed CAP or CAPDSH3 in 3T3-L1 adipocytes and
evaluated insulin-stimulated tyrosine phosphorylation. Both pro-
teins were found in the triton-soluble and insoluble fractions
(Fig. 3a), and expressed at levels around ®vefold higher than the
endogenous CAP protein (data not shown). Expression of CAP or
CAPDSH3 had no effect on the tyrosine phosphorylation of the
insulin receptor b-subunit or its predominant substrate, IRS-1
(Fig. 3b). Similarly, there was no change in the ability of insulin to
stimulate the phosphorylation of two downstream targets, AKT/
protein kinase B and mitogen-activated protein kinase (MAPK),
that are activated as a consequence of well characterized phosphory-
lation cascades (Fig. 3b). As AKT activation occurs as a direct
consequence of phosphatidylinositol-3-OH kinase (PI(3)K)
stimulation12, these data also show that the expression of CAPDSH3
did not affect the stimulation of PI(3)K activity by insulin.
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Figure 3 CAPDSH3 mutant blocks the translocation of phosphorylated Cbl into lipid rafts.
a, A representative FLAG immunoblot of the triton-soluble (TS) fraction (top) and triton-
insoluble pellet (TIP) fraction (bottom) of 3T3-L1 adipocytes expressing LacZ, CAP or
CAPDSH3. b, Lysates from basal and insulin-treated adipocytes expressing LacZ, CAP or
CAPDSH3 were immunoblotted with anti-phosphotyrosine (top), phospho-AKT (middle)
and phospho-MAPK (bottom) antibodies. c, Cbl was immunoprecipitated from the triton-
soluble fraction of lysates from basal and insulin-treated adipocytes expressing LacZ, CAP
or CAPDSH3. Immunoprecipitates were resolved by SDS±PAGE, immunoblotted with
monoclonal phosphotyrosine antibodies and re-probed with the Cbl antibody. A
representative blot is shown within the graph. Films were scanned and quanti®ed, and the
ratio of total Cbl to phospho-Cbl was calculated. d, Cbl was immunoprecipitated from the
triton-insoluble pellet fraction of lysates from basal and insulin-treated adipocytes
expressing LacZ, CAP or CAPDSH3. Immunoprecipitates were resolved and analysed as
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Figure 4 Overexpression of CAPDSH3, but not CAP, attenuates the metabolic effects of
insulin. 3T3-L1 adipocytes were transfected by electroporation and the stimulation of
[14C]2-deoxyglucose uptake (a), [14C]-glucose incorporation into glycogen (b) and [14C]-
glucose incorporation into lipid (c) by insulin were measured. Results are the mean 6
standard error of three separate experiments, each performed in triplicate. Double
asterisk: signi®cant difference, P , 0.01, n = 3.
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the protein to the insulin receptor by CAP2. As CAPDSH3 does not
bind either Cbl or the insulin receptor, overexpression of CAP or
CAPDSH3 had no effect on insulin-stimulated Cbl phosphorylation
in the triton-soluble fraction (Fig. 3c). However, CAPDSH3 over-
expression signi®cantly reduced the appearance of tyrosine phos-
phorylated Cbl in the triton-insoluble fraction (Fig. 3d). These data
indicate that the expression of the N-terminal ¯otillin-binding
domain of CAP may be able to block the interaction of the
endogenous CAP±Cbl complexes with ¯otillin, thus preventing
the appearance of phosphorylated Cbl in the triton-insoluble
plasma membrane subdomain.
To investigate the role of the association of the CAP±Cbl complex
with ¯otillin in insulin action, we evaluated the effect of CAPDSH3
expression on insulin-stimulated [14C]2-deoxyglucose uptake in
3T3-L1 adipocytes (Fig. 4a). Although wild-type CAP had no effect,
expression of CAPDSH3 led to a reduction of about 50% in insulin-
stimulated glucose uptake, without affecting basal activity. Similar
experiments were done to evaluate the effect of LacZ, CAP or
CAPDSH3 on glycogen and lipid synthesis (Fig. 4b, c). As observed
for glucose uptake, the expression of CAPDSH3 inhibited the
insulin-stimulated incorporation of [14C]glucose into glycogen
and lipid, whereas expression of CAP had no effect. Considering
that the average ef®ciency of transfection by electroporation in these
cells is about 50% (ref. 9), the observed reduction in glucose
utilization may indicate that the expression of the CAPDSH3
mutant almost completely blocked the metabolic actions of insulin.
Figure 5 CAPDSH3 blocks insulin-stimulated GLUT4 and IRAP translocation to the
plasma membrane, without effecting translocation of CI/M6PR. a, Differentiated 3T3-L1
adipocytes were transfected with GLUT4±EGFP plus vector, Flag±CAP or Flag±
CAPDSH3, and allowed to recover for 18 h. The cells were treated without or with 100 nM
insulin for 30 min. Cells were ®xed and ¯uorescence visualized by confocal microscopy.
This is a representative collection of 6±9 cell images per ®eld. b, Number of
GLUT4±EGFP transfected cells displaying visually detectable plasma membrabe (PM) rim
¯uorescence. c, d, Number of EGFP±IRAP- and CI/MPR±EGFP-transfected cells
displaying visually detectable rim ¯uorescence. These data were obtained by blind
counting of more than 75 cells from three independent experiments. Double asterisk:
signi®cant difference, P , 0.01, n = 3.
Figure 6 CAPDSH3 inhibits insulin-stimulated endogenous GLUT4 but not GLUT1
translocation. Differentiated 3T3-L1 adipocyte nuclei were microinjected with 0.2 mg ml-1
of MBP-Ras plus either the CAP or CAPDSH3 cDNA. After 24 h recovery, cells were
treated without or with 100 nM insulin for 30 min. Plasma membrane sheets were
prepared and MBP-Ras was detected with a FITC-labelled anti-MBP antibody and GLUT4
with a Cy5-labelled anti-GLUT4 antibody. These are representative images obtained from
®ve independent experiments and visualization of 60±91 individual plasma membrane
sheets.
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The stimulation of glucose uptake and utilization by insulin is
dependent upon the translocation of the insulin-responsive glucose
transporter GLUT4 from intracellular storage sites to the plasma
membrane. To investigate how CAPDSH3 blocks glucose transport,
the translocation of GLUT4 was directly examined. We electropo-
rated 3T3-L1 adipocytes with pcDNA3, CAP or CAPDSH3 together
with a construct encoding an enhanced green ¯uorescent protein
fusion of GLUT4 (GLUT4±EGFP; Fig. 5a). As expected, insulin
stimulated the translocation of GLUT4±EGFP to the plasma mem-
brane in cells transfected with pcDNA3 or CAP, as detected by the
presence of a continuous rim of cell-surface EGFP ¯uorescence. In
contrast, expression of CAPDSH3 markedly inhibited GLUT4±
EGFP translocation to the cell surface in response to insulin.
Expression of CAPDSH3 not only decreased the number of cells
displaying GLUT4±EGFP at the cell surface, but also decreased the
plasma membrane intensity in those cells that still had observable
rim ¯uorescence (arrows). Quanti®cation of the number of trans-
fected cells displaying any visual rim ¯uorescence indicated that
following pcDNA3 or wild-type CAP transfection, about 65% of the
cells displayed insulin-stimulated translocation, which was reduced
to less than 30% in cells transfected with CAPDSH3.
The insulin-responsive aminopeptidase (IRAP) is localized in the
same compartments as GLUT4 in adipocytes, and undergoes an
identical pattern of insulin-stimulated translocation13,14. As
expected, expression of CAPDSH3 blocked insulin-stimulated
translocation of EGFP±IRAP, in a manner identical to that observed
with EGFP±GLUT4 (Fig. 5c). Insulin also stimulates the net exo-
cytosis of the cation-independent mannose-6-phosphate/IGF-2
receptor (CI/MPR). This protein is located in compartments distinct
from the GLUT4/IRAP-containing vesicles, and travels between the
trans-Golgi network and the late endosomes in the absence of
insulin15±17. Expression of CAPDSH3 had no signi®cant effect on
the insulin-stimulated translocation of a CI/MPR±EGFP fusion
protein (Fig. 5d), in contrast to its effects on GLUT4 and IRAP.
As the determination of translocation in these intact cell assays
relies on the qualitative strength of plasma membrane rim ¯uores-
cence from overexpressed EGFP-fusion proteins, we also examined
the translocation of the endogenous GLUT4 and GLUT1 proteins in
isolated plasma membrane sheets from microinjected 3T3-L1
adipocytes (Fig. 6). To identify the plasma membrane sheets derived
from the microinjected cells, the wild-type CAP and CAPDSH3
complementary DNAs were microinjected into the cells with the
maltose-binding protein (MBP)-Ras cDNA18. In the absence of
insulin, microinjection of MBP-Ras and CAPDSH3 resulted in the
identi®cation of four MBP-Ras positive sheets in the ®elds shown in
Fig. 6 (arrows).
In the absence of insulin, GLUT4 remained intracellular, with low
levels of plasma membrane GLUT4 in both the microinjected and
surrounding non-microinjected cells. Insulin stimulation resulted
in the appearance of GLUT4 at the plasma membrane in the non-
microinjected cells, but not in the cells microinjected with
CAPDSH3. In contrast, microinjection of cells with the wild-type
CAP cDNA had no signi®cant effect on GLUT4 translocation,
compared with the surrounding non-microinjected cells. Quanti®-
cation of these data showed that insulin stimulated the transloca-
tion of GLUT4 in 87 6 6% of the cells microinjected with wild-type
CAP. In contrast, expression of CAPDSH3 resulted in a marked
reduction, with only 28 6 10% of the plasma membrane sheets
displaying any detectable GLUT4 translocation.
Like CI/MPR, the GLUT1 glucose transporter resides in vesicle
compartments distinct from GLUT4, and undergoes modest insu-
lin-stimulated plasma membrane translocation19. To assess the
speci®city of CAPDSH3, we examined the translocation of the
endogenous GLUT1 protein in microinjected 3T3-L1 adipocytes
(see Supplementary Information Fig. 4). Insulin modestly stimu-
lated the translocation of GLUT1. However, this effect of insulin was
not impaired by the microinjection of either wild-type CAP or
CAPDSH3 cDNAs. Under these conditions, 94 6 2% and 87 6 6%
of the cells microinjected with wild-type CAP and CAPDSH3,
respectively, displayed insulin-stimulated GLUT1 translocation.
Together, these data show that the CAPDSH3 mutant has a
dominant-interfering effect on insulin-stimulated translocation of
GLUT4/IRAP-containing vesicles to the plasma membrane, without
affecting general exocytosis or other insulin-regulated vesicle traf-
®cking processes.
The stimulation of glucose transport by insulin is a complex,
multistep process involving the movement of intracellularly seques-
tered GLUT4-containing vesicles to the cell surface, followed by
docking and fusion with the plasma membrane19. The activation of
PI(3)K and its downstream kinases AKT and/or protein kinase
Cz/l (PKCz/l) are required for this process, as inhibitors and
dominant-negative mutants of PI(3)K, AKT and PKCz/l can
completely block insulin-stimulated glucose transport20. There is
compelling evidence, however, that activation of PI(3)K-dependent
pathways is not suf®cient to induce glucose transport. Other growth
factors and adhesion molecules that can activate PI(3)K and its
downstream kinases have no effect on glucose transport or GLUT4
translocation21±23. Furthermore, cell-permeable derivatives of phos-
phatidylinositol 3,4,5-trisphosphate can stimulate GLUT4 translo-
cation only when cells are pre-treated with insulin24. These data
suggest that insulin must generate at least two independent signals
to stimulate glucose transport, one dependent on and another
independent of PI(3)K.
What is the second signal needed for insulin-stimulated glucose
transport? Our data indicate that this pathway is probably initiated
by the phosphorylation of Cbl and its subsequent segregation into
lipid raft subdomains of the plasma membrane. This process is
independent of wortmannin (data not shown) and requires the
adapter protein CAP2. CAP expression and Cbl phosphorylation
correlate well with insulin sensitivity25. The appearance of phos-
phorylated Cbl in the triton-insoluble fraction, its association with
the src kinase fyn, and the subsequent phosphorylation of the
caveolar protein caveolin are speci®cally stimulated by insulin.
Insulin-stimulated Cbl tyrosine phosphorylation is observed only
in insulin-sensitive cells and tissues in which CAP is also
expressed1,3,11. Although inhibition of Cbl phosphorylation in the
triton-insoluble complexes with the CAPDSH3 mutant does not
interfere with PI(3)K-dependent and ras-dependent signalling,
disruption of this association markedly attenuates insulin-stimu-
lated GLUT4 translocation and glucose uptake. Whether the
GLUT4 protein itself resides in the triton-insoluble microdomains
of the plasma membrane remains uncertain26±28. However, it is
possible that the association of the CAP±Cbl complex with other
proteins in lipid rafts may lead to the segregated generation of a
speci®c signal, perhaps directing fusion of the GLUT4 vesicle to the
plasma membrane in a domain near the lipid raft. M
Methods
Cell culture and transfection of HEK293Tcells and 3T3-L1 adipocytes
HEK293T cells were maintained in Dulbecco's Eagle Medium (DMEM) containing 10%
fetal bovine serum at 37 8C and 5% CO2. HEK293T cells were transfected with a
mammalian CaPO4 transfection kit as described by the manufacturer (Stratagene). 3T3-
L1 preadipocytes were cultured in DMEM containing 25 mM glucose, 10% calf serum at
37 8C and 5% CO2. Con¯uent cultures were induced to differentiate into adipocytes as
described29. 3T3-L1 adipocytes were transiently transfected by electroporation as
described9. The cells were then allowed to adhere to collagen-coated tissue culture dishes
for 30±48 h before serum starvation and insulin treatment. The average ef®ciency of
transfection was 50% as evaluated by b-galactosidase staining.
In vitro protein associations
The Flag±CAP expression construct was made as described2. We constructed Flag-
epitope-tagged CAPDSH3 by restriction digestion, removal of the SH3 domains of the
CAP cDNA and religation of the CAP expression construct. CAPDSH3 does not associate
with Cbl or the insulin receptor. We lysed HEK293T cells overexpressing CAP or
CAPDSH3 in HNTG buffer containing protease inhibitors and sodium orthovanadate29.
Lysates from HEK293T cells were incubated with GSTalone or GST±¯otillin immobilized
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on glutathione agarose beads for 1 h at 4 8C. Beads were then washed extensively with
HNTG and retained proteins were eluted in 4 ´ Laemmli sample buffer, heated for 5 min at
100 8C, separated by SDS±PAGE and immunoblotted with either a Flag antibody
(Stratagene) or a polyclonal c-Cbl antibody (Santa Cruz).
GLUT4-EGFP, IRAP-EGFP and CI/M6PR-EGFP translocation assays
We constructed all EGFP fusion proteins and performed translocation assays as described9.
Brie¯y, 3T3-L1 adipocytes were electroporated with 50 mg of the EGFP-tagged plasmid
and 200 mg of empty vector, CAP or CAPDSH3 constructs. Adipocytes were replated,
allowed to recover overnight and stimulated with or without 100 nM insulin for 30 min.
The cells were then ®xed and EGFP ¯uorescence was analysed by confocal immuno-
¯uorescence microscopy.
Single cell microinjection and plasma membrane sheet isolation
We grew 3T3-L1 adipocytes on 35-mm tissue culture dishes. Before microinjection, the
medium was changed to Lebovitz's L-15 medium containing 0.1% bovine serum albumin
and microinjection was carried out as described30. The cells were allowed to recover for
24 h and plasma membrane sheets were prepared as described18. The bound plasma
membranes sheets were then subjected to confocal ¯uorescent microscopy.
Metabolic assays
We determined 2-deoxyglucose uptake, glycogen synthesis and lipogenesis as described29.
Immunoprecipitations and immunoblotting
After insulin treatment, we washed electroporated adipocytes with PBS and lysed them in
MBS buffer containing protease inhibitors and sodium orthovanadate. Lysed cells were
kept at 4 8C to prevent degradation of caveolar complexes. The triton-insoluble pellet
fraction was generated as described11. This triton-insoluble pellet fraction was solubilized
in SOL buffer containing protease inhibitors and sodium orthovanadate as described11.
Lysates and immunoprecipitations were resolved by SDS±PAGE and transferred to
nitrocellulose for immunoblot analysis.
Immunoprecipitations were performed using a polyclonal c-Cbl antisera (Santa Cruz).
We used monoclonal 4G10 anti-phosphotyrosine antibodies (Upstate Biotechnology) to
blot for IR, IRS-1 and Cbl tyrosine phosphorylation. Polyclonal phospho-AKT and
phospho-MAPK antibodies (New England Biolabs) were used to probe for activated AKT
and MAP kinase. Monoclonal caveolin I antibodies (Transduction Labs) were used to
evaluate protein content of the resolved TIP fractions. We used horseradish peroxidase
(HRP)-conjugated secondary antibodies and ECL chemiluminesence for immunoblot
detection.
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Successful viral infection requires viruses to redirect host bio-
chemistry to replicate the viral genome, and produce and assem-
ble progeny virions. Cellular heat-shock responses, which are
characterized as elevation and relocalization of heat-shock pro-
teins, occur during replication of many viruses1±7. Such responses
might be host reactions to the synthesis of foreign protein, or
might be irrelevant consequences of the viral need to activate
transcription. Alternatively, as heat-shock proteins can facilitate
protein folding8,9, activating a heat-shock response might be a
speci®c virus function ensuring proper synthesis of viral proteins
and virions. It is not possible to determine whether heat-shock
response is essential for virus replication, because the implicated
© 2000 Macmillan Magazines Ltd
